健康な被験者におけるオルフォルグリプロン（LY3502970）の単回投与と複数回投与を比較する試験

基本情報

NCT ID

NCT06692348

ステータス

完了

試験のフェーズ

第1相

試験タイプ

介入

目標被験者数

86

治験依頼者名

Eli Lilly and Company

概要

The main purpose of this study is to assess and compare a single capsule and multiple capsules of Orforglipron based on the amount that gets into the blood stream and how long it takes the body to get rid of it, when given to healthy participants under fasted and fed conditions. How the body handles and eliminates the study drug after meals and on an empty stomach will be measured. Information about any adverse effects experienced will be collected and the safety and tolerability of Orforglipron will also be evaluated. The study will last approximately 21 weeks, including a screening period.

対象疾患

介入

依頼者（Sponsor）

実施施設 (3)